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Executive Summary 
The cesarean section (C-section) rate has risen dramatically in the past several decades 
both in the United States and throughout the world.  Domestically, the C-section rate has risen 
from 4.5% in 1965 to 32.2% in 2014 (National Partnership for Women & Families [NPWF], 
2016a).  Worldwide, roughly 19% of births occur via C-Section (Betrán et al., 2016).  
Concurrently, the induction rate has also increased, doubling in the United States between 1990 – 
1998 (Davey & King, 2016).  As of 2014, about 23% of all women had their labors induced in 
the United States (NPWF, 2016b).  Furthermore, the trend toward electively inducing labor is 
gaining traction with patients choosing to induce labor for logistical reasons, and physician or 
patient convenience (Tam, Conte, Schuler, Malang, & Roque, 2013).   
  There are many drugs used to induce or augment labor, oxytocin and misoprostol being 
two of the most common.  Labor and delivery nurses administer these drugs on a regular basis 
and usually have developed biases regarding each.  However, new graduate labor and delivery 
nurses as well as student nurses have not had time to develop any preconceived notions and may 
very well be unaware of the evidence surrounding oxytocin and misoprostol which led to the 
following PICOT question: In nursing students and new graduate labor and delivery nurses (P), 
how does education regarding delivery outcomes of labor inducing agents, oxytocin and 
misoprostol specifically, (I) compare to no education about labor inducing agents (C) affect their 
perceptions of labor experiences (O) over 3 months following education (T)?   
The literature is conflicted regarding the effects oxytocin has on labor outcomes but 
presents misoprostol conferring significant benefits on achieving a vaginal delivery.  Presenting 
the evidence to new graduate labor and delivery nurses as well as nursing students gleaned 
regarding the effects oxytocin and misoprostol have on delivery outcomes gleaned from 12 
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scholarly articles will hopefully educate these nurses and guide them into forming their own 
opinions, based on the evidence, regarding the safety and efficacy of these labor inducing agents.  
After the evidence is presented, the participants can see the actual effects oxytocin and 
misoprostol have through 3 months of clinical experience. Then, the participants can engage in 
meaningful dialogue about ways to optimize the labor and delivery experience using the 
perceptions they have formed based on the education provided and clinical experience.  Finally, 
the participants can take what they have learned, bring it to their bedside care, and find 
innovative ways to promote a healthy, safe delivery for both mother and baby with the hope and 
possibility of reducing the C-section potential through their nursing interventions.   
1. Rationale 
The C-section rate has reached unacceptable levels. As of 2018, the C-section rate was 
35% in Texas, which was one of the higher rates in the nation (Centers for Disease Control and 
Prevention [CDC], 2018).  The risks present with a C-section far outweigh those with a vaginal 
delivery.  A woman who delivers via C-section will have a longer hospital stay and a higher 
morbidity and mortality rate (Sandall et al., 2018).  Additionally, the induction rate has also risen 
with oxytocin and misoprostol being 2 commonly administered agents.   In fact, Saccone et al. 
(2016) found that oxytocin is the preferred agent in up to 50% of inductions in developed 
countries. 
The literature is divided regarding the effects of oxytocin but clearly demonstrates that 
misoprostol confers significant benefits on achieving a vaginal delivery which creates a 
conundrum regarding best practice in labor and delivery. New graduate nurses as well as future 
nurses need to be aware of the disparity and must receive education while they still have an open 
mind prior to any preconceptions being formed.  It is therefore important to present the evidence 
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surrounding these agents to the participants in order to ignite a dialogue amongst each other, and 
possibly with their preceptors, about the safety and efficacy of oxytocin and misoprostol 
regarding delivery outcomes in order to for the participants to discuss innovative promote an 
optimal patient experience based on the literature results presented.  This is a topic worth 
bringing awareness to as the C-section and induction rates have reached unacceptable levels. 
Understanding the outcomes of induction methods can, hopefully, encourage new graduate labor 
and delivery nurses and students to seek out further information and engage in meaningful 
dialogue based on the evidence to find ways to improve quality of care and promote a safe, 
vaginal delivery for both mother and baby. 
1.1 Project Goals 
 The goal of any change project is to effect innovative, sustainable change that will 
positively affect patients (Thomas, Seifert, & Joyner, 2016).  Upon future project 
implementation, one of the major goals of my project is to present the evidence in a meaningful 
manner that will enhance the participants’ perceptions of labor experiences and stimulate a 
profound dialogue amongst the participants regarding ways to optimize the labor and delivery 
experience.  Nurses often do not realize the effect they have on delivery outcomes and the 
laboring experience.  There are many nursing interventions that can be used when administering 
oxytocin and misoprostol to promote a safe vaginal delivery.  I want the participants of my study 
to form perceptions of labor experiences based on the evidence provided and brainstorm 
innovative ways to optimize labor and delivery with the ultimate goal of decreasing the 
unacceptably high C-section rate while empowering women to take a greater stake in their own 
healthcare decisions. 
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 An additional goal is to promote a spirit of inquiry among the participants.  I want them 
to see the conflicting evidence was well as the dilemma it presents regarding best practice in 
labor and delivery.  Nursing and medicine are evolving professions as new studies are being 
undertaken frequently.  It will be important for the participants in my project to feel empowered 
to seek out current evidence in order to continually promote best practice in labor and delivery. 
2. Literature Synthesis 
I began my literature search in 2018 and limited my findings to within the past 5 years.  I 
searched the CINAHL, EMBASE, PubMed, and Cochrane databases using the key words 
“labor”, “labor induction”, “oxytocin”, and “misoprostol” as well as any variations thereof.  I 
found many articles that included not just oxytocin and misoprostol, but various other methods 
of labor induction.  The project initially focused on oxytocin alone and evolved within the last 
year to include misoprostol.  If oxytocin and/or misoprostol showed significant results, they were 
included in the articles I chose to use.  I omitted any articles that did not specifically focus on at 
least one of these two agents. 
Tam, Conte, Schuler, Malang and Roque (2013) conducted a retrospective cohort study 
of delivery outcomes in low-risk women at term undergoing elective induction with N = 848.  
The purpose of the study was to determine labor outcomes of elective inductions in term, low-
risk women.  The study aimed to establish criteria for elective induction of labor by comparing 
successful vaginal delivery versus operative interventions.  Most patients (73.7%) received 
oxytocin as the primary induction agent.  Most patients who received oxytocin alone resulted in a 
vaginal delivery (n = 525, 75.7%).  However, administering oxytocin to nulliparous women with 
unfavorable cervical exams resulted in more operative deliveries (α = 0.05).  In comparison, 
misoprostol resulted in an increased induction length but had only 1.95% of patients deliver via 
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C-section.  Overall, this study suggests that oxytocin or misoprostol use during labor can 
decrease the risk of a C-section on most women compared to other induction methods.   
Davey and King (2016) conducted a cross-sectional analysis of descriptive studies with N 
= 42,950.  The purpose of the study was to examine the risk of a cesarean section following both 
induction of labor and individual methods used to induce or augment labor in term, low risk 
pregnancies.  The aim of the study was to describe and analyze the outcomes that occur 
following induction of labor in uncomplicated nulliparous pregnancies.  Each method of 
induction or augmentation was found to have increased odds of a C-section, with oxytocin and 
prostaglandin, with or without an amniotomy, having the greatest increase.  Oxytocin and 
prostaglandin induction without an amniotomy resulted in relative risk ratio (RRR) = 11.83 (95% 
CI 8.4,16.6), adjusted RRR = 4.06 (95% CI 2.8, 5.8) with p < 0.0001.  Oxytocin and 
prostaglandin induction with an amniotomy resulted in RRR = 10.19 (95% CI 8.8, 11.9), 
adjusted RRR = 3.79 (95% CI 3.2, 4.5) with p < 0.0001.  Results imply that minimizing the use 
of elective inductions may prove beneficial in reducing the C-section rate. 
Hidalgo-Lopezosa, Hidalgo-Maestre, and Rodríguez-Borrego (2016) conducted a 
descriptive study with N = 338.  The purpose of the study was to compare C-section rates, 5-
minute Apgar scores, arterial pH values of umbilical cord blood and type of neonatal 
resuscitation required, between women who were and were not stimulated with oxytocin.  The 
aim of the study was to assess the effects of labor induction or augmentation with oxytocin on 
the maternal and neonatal outcomes.  They found that nulliparous women were more likely to 
have a C-section after oxytocin use during labor (n = 45, crude Odds Ratio = 5.76, 95% CI 2.55-
13.0, p < 0.001).  Multiparous women who received oxytocin also showed an increase in C-
sections (n = 8, crude Odds Ratio = 6.95, 95% CI 1.41-34.27, p = 0.014).  The results of this 
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study suggest that oxytocin increases the risk of a C-section on both nulliparous and multiparous 
women.  These results should be viewed with caution, though, due to the limited sample size.   
Saccone et al. (2017) conducted a systematic review and meta-analysis regarding 
discontinuing or continuing oxytocin once active labor has been achieved with N = 1,538.  The 
purpose of the study was to evaluate how cesarean delivery was affected by both discontinuing 
and continuing oxytocin administration once active labor had been achieved.  The aim of the 
study was to evaluate both benefits and harms of oxytocin discontinuation compared with 
continuing oxytocin administration after active labor has been reached.  The subgroups consist of 
n = 764 in the oxytocin discontinuation group and n = 774 in the group that continued oxytocin.  
Saccone et al. (2017) found that women who discontinued oxytocin had a significantly lower risk 
of delivering via C-section compared to the women who continued oxytocin throughout labor 
(9.3% compared to 14.7%, RR 0.64, 95% CI 0.48-0.87).  Results suggest that continued use 
throughout labor can increase a woman’s chances of a C-section. 
Aalami-Harandi, Karamali, and Moeini (2013) conducted a randomized controlled trial 
exploring the safety and efficacy of oxytocin and oral misoprostol administration to induce labor 
with N = 256.  The purpose of the study was to assess the efficacy and safety of administering 
oral misoprostol and intravenous oxytocin to induce labor in term pregnant women.  The aim of 
the study was to determine the safety and efficacy of 25 µg of misoprostol every 2 hours 
compared to IV infusion of 10 units of oxytocin for induction of labor in term pregnant women. 
The subgroups consist of n = 128 for oxytocin administration and n = 128 for oral misoprostol 
administration.  Aalami-Harandi et al. (2013) discovered that the oral misoprostol group 
experienced a higher rate of vaginal deliveries (n = 122, 79.7%, p < 0.001) compared to the 
oxytocin group (n = 79, 61.7%, p < 0.001).  Furthermore, the oxytocin group showed a 
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significantly higher risk of C-section delivery (n = 49, 38.3%, p < 0.001) compared to the oral 
misoprostol group (n = 26, 20.3%, p < 0.001).  The results express that oral misoprostol may be a 
safer choice to achieve a vaginal birth.  
Alfirevic et al. (2016) conducted a systematic review and network meta-analysis focusing 
on an extensive variety of induction methods and labor outcomes, including the risk of a C-
section with N > 100,000.  The purpose of the study was to summarize findings regarding 
efficacy and cost-effectiveness for methods used to induce labor at term.  The aim of the study 
was to compare the efficacy and cost-effectiveness of a multitude of methods to induce labor at 
term.  Interestingly, oxytocin in combination with artificial rupture of membranes (AROM) 
demonstrated the lowest risk for not delivering vaginally within 24 hours (OR = 0.05, 95% CI 
0.07-0.32).  Oxytocin administration alone established a moderate risk of a C-section (OR = 
0.93, 95% CI 0.75-1.14) compared to the other methods tested; titrated low-dose oral 
misoprostol actually exhibited the lowest odds of a C-section (OR = 0.62, 95% CI 0.47-0.80).  
Oxytocin with AROM also demonstrated a moderate risk for a C-section (OR = 0.89, 95% CI 
0.57-1.34).  These results suggest that it may be prudent to combine oxytocin with AROM if 
oxytocin is the drug of choice to induce or augment labor but using misoprostol may be a safer 
option achieve a vaginal delivery.  
Hurakadli (2016) conducted a partographic comparison of 100 primigravida women 
undergoing induction with oral misoprostol, vaginal misoprostol, oxytocin or spontaneous labor 
with n = 25 for each group.  The purpose of the study was to study the cervical progress of labor 
in primiparous women in both spontaneous labor and in those undergoing induced labor with 
oxytocin, oral misoprostol, and vaginal misoprostol. The aim of the study was to study the 
effects oxytocin and prostaglandins have on labor outcomes in order to suggest the best agent for 
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labor induction. Oxytocin had the shortest induction to delivery interval (735 + 238, p < 0.05). 
However, oxytocin exhibited the highest C-section rate of the four groups with 20% delivering 
via C-section while oral misoprostol showed the lowest C-section rate (4%) (p = 0.17), 
suggesting that oral misoprostol would be beneficial in achieving a vaginal delivery. These 
results should be viewed with caution, though, due to the small sample size.  
Mikolajczyk et al. (2016) examined data based on early, middle, and late admission to 
laboring units, dilation upon admission, and oxytocin administration in each stage with N = 
1202.  The purpose of the study was to study the underlying causes of increasing rates of C-
sections, specifically any association with time of admission and oxytocin use.  The aim of the 
study was to determine if there is an association between cervical dilation upon admission and 
labor progression as well as the risk of delivering via C-section during the first and second stages 
of labor.  The study also aimed to determine if oxytocin influenced delivering by C-section.  
Oxytocin usage was associated with an increased risk of C-sections among the total sample 
(12.5% during 1st stage of labor, 6.6% during 2nd stage of labor, p < 0.0001).  It also depicted 
increased C-sections among women who were less than 3.5 centimeters dilated upon admission 
(12.6 % during 1st stage of labor, 8.6% during second stage of labor, p = 0.0007).  However, with 
women who were greater than 4.5 centimeters dilated upon admission, oxytocin was not 
associated with a higher risk of C-section (7.6% during 1st stage of labor, 0% during second stage 
of labor, p = 0.11).  These conflicting results warrant further studies on this topic.  
Mishanina et al. (2014) conducted a systematic review and meta-analysis of various 
induction methods, including oxytocin, with N = 31,085.  The purpose of the study was to 
discover whether the risk of delivering via C-section was higher after inducing labor.  The aim of 
the study was to compare the risk of delivering by C-section after both inducing labor and 
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expectant management in order to guide clinical decision making.  Mishanina et al. (2014) 
discovered that oxytocin use alone did not confer any increased C-section risk (RR 1.03, 95% CI 
0.83-1.23, I² 0.0%), but exhibited a significant risk when used in combination with an AROM 
(RR 0.96, 95% CI 0.72-1.29, I² 0.0%).  Misoprostol was associated with a significant reduction 
in C-section risk (RR 0.62, 95% CI 0.48-0.81, I² 0.0%), suggesting it made be a more prudent 
option to achieve a vaginal delivery.  It should be noted, though, that it was not specified whether 
misoprostol was given orally or inserted. 
Acharya, Devkota, Bhattarai, and Acharya (2017) conducted a hospital-based 
observational study regarding the effects oxytocin and misoprostol have on labor outcomes with 
N = 205.  The purpose of the study was to explore outcomes associated with oxytocin and 
misoprostol induction of labor.  The aim of the study was to discover both maternal and fetal 
outcomes associated with oxytocin and misoprostol induction.  The C-section rate was 
comparable among oxytocin (n = 14, 28%) and misoprostol (n = 39, 28.3%).  However, the C-
section rate did increase when oxytocin was given after a failed misoprostol failed to induce 
labor (n = 15, 88%).  Finally, achieving delivery in less than 12 hours was achieved with more 
frequency with oxytocin (n = 20, 43.5%) compared to misoprostol (n = 25, 18.4%).  These 
results suggest that oxytocin confers a quicker delivery, but neither oxytocin nor misoprostol has 
any significant effect on achieving a vaginal delivery.  However, these results should be viewed 
with caution due to the small sample size. 
Sharada, Warrier, Reddy, and Thulasi (2018) conducted a hospital-based observational 
study surrounding the delivery outcomes achieved after oxytocin and misoprostol administration 
for induction of labor with N = 327.  The purpose of the study was to compare maternal and 
neonatal outcomes after oxytocin and misoprostol administration.  The aim of the study was to 
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discover any differences among both maternal and neonatal outcomes after inducing labor with 
either oxytocin or misoprostol after 37 weeks gestation.  The C-section rate was slightly higher 
with oxytocin (n = 52, 36%) compared to misoprostol (n = 60, 32.7%).  The induction to delivery 
interval was quicker with oxytocin administration (mean 18.4 hours standard deviation 3.2 
hours) compared to misoprostol administration (19.1 hours standard deviation 2.8 hours).  These 
results, which should be viewed with caution due to the small sample size, suggest that oxytocin 
confers a slightly increased risk on delivering via C-section but promotes a quicker induction to 
delivery interval. 
Wallstrom et al. (2018) conducted a retrospective cohort study focusing on delivery 
outcomes after induction of labor using a variety of agents with N = 4002.  The purpose of the 
study was to explore the safety and effects misoprostol and other induction methods have on 
delivery method, Apgar scores, cord blood pH, postpartum hemorrhage, and active time of labor.  
The aim of the study was to compare delivery outcomes of several induction agents to oral 
misoprostol.  Most patients who received misoprostol for labor induction achieved a vaginal 
delivery (n = 1367, 82%).  When presented with an immature cervix, oral misoprostol portrayed 
the lowest risk a C-section for both multiparous women (11%, p < 0.01) and nulliparous women 
(23%, p < 0.01).  Interestingly, without accounting for other factors, such as an immature cervix, 
oxytocin depicted the lowest risk for a C-section (n = 28, 12%).  The oxytocin results should be 
viewed with caution due to not considering influential risk factors.  These results strongly 
suggest that misoprostol is a safe choice when trying to achieve a vaginal delivery, especially on 
those women undergoing induction who present with an immature cervix. 
Only 3 studies, Wallstrom et al. (2018), Tam et al. (2013), and Mikolajczyk et al. (2016), 
showed oxytocin conferring a decreased C-section risk but the latter was only in women who 
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were dilated greater than 4.5 cm on admission.  Interestingly, Davey and King (2016) and 
Mishanina et al. (2014) associated oxytocin with an increased C-section risk when combined 
with AROM while Alfirevic et al. (2016) displayed a decreased risk.  Furthermore, Acharya et 
al. (2017) showed an increased risk of a C-section when oxytocin was given after misoprostol 
failed to induce labor.  Mishanina et al. (2014), Alfirevic et al. (2016), Hurakadli (2016), 
Aalami-Harandi et al. (2013), Tam et al. (2013), and Wallstrom et al. (2018) all depicted 
misoprostol as having a decreased risk of a C-section suggesting that it may indeed be a more 
effective option to achieve a vaginal delivery. 
3. Stakeholders 
It will be important to involve not only those directly affected by the project, but also 
those who will have a vested interest in the outcome in order to ensure a successful, sustainable 
change design.  The support of nursing leaders is paramount, which in this case refers to 
Women’s Services Nurse Managers and the course leader for a Maternal/Child nursing course.  
These leaders have a vested interest in the outcome as it will hopefully have a positive effect on 
the care their nurses and students provide.  Furthermore, it will be vital to engender their support 
as they have an invaluable influence on strengthening quality and integration of care the nurses 
and students provide (Sfantou et al., 2017). 
The new graduate labor and delivery nurses and student nurses participating in the project 
are debatably one of the most influential groups of stakeholders affected.  These participants will 
be the ones reviewing the evidence and seeing how oxytocin and misoprostol affect labor 
outcomes in clinical practice.  They have an entrusted interest in the education provided as it will 
be their perceptions of laboring experiences that will hopefully be influenced.  These participants 
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can have a great impact on enhancing labor and delivery based on education and experiences 
gleaned during the project.  
Arguably the most important stakeholder would be labor and delivery patients.  This 
population served as the inspiration for and remains the driving force behind the project.  One of 
the major goals is to improve laboring experiences and decrease the C-section rate.  Hopefully 
the participants of my project will use the evidence to develop their perceptions of labor 
experience and engage in meaningful dialogue amongst each other to find ways to enhance labor 
and delivery for this population.  
4. Planned Implementation 
The actualization of the project will take about 4-5 months to complete.  The first step is 
to administer a survey, in the form of a Likert scale, to new graduate labor and delivery nurses 
and student nurses participating in the project (Appendix A).  The purpose of administering this 
survey at the start of the project is to assess any initial perceptions of labor experiences the 
participants have regarding the effects oxytocin and misoprostol have on labor outcomes and 
experiences.   
The second step is to hold an educational offering for the participants.  A PowerPoint 
presentation would present evidence-based information gleaned from 12 scholarly articles 
presenting evidence regarding how oxytocin and misoprostol affect delivery outcomes.  The 
presentation will be developed and presented by myself. 
The third step is to allow 3 months for clinical experience.  It is important to allow 
participants to see first-hand the effects oxytocin and misoprostol have on labor outcomes and 
experiences.  This time frame should allow enough time for each participant to have adequate 
exposure to oxytocin and misoprostol administration.  
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After the 3 months of clinical experience, the same Likert scale survey needs to be 
administered to the participants again in order to see if their perceptions of labor experiences 
have changed after they received the evidence-based education and completed clinical 
experiences.  This survey also needs to be administered to nurses and students who did not 
participate in the project.  This would provide a sufficient comparison to see if the education 
provided truly had an effect. 
The final step will be to guide a roundtable discussion within 1-2 weeks of survey 
completion. The nurses and students can discuss their feelings amongst each other, and with their 
preceptors if possible, on how their perceptions of labor experiences have changed based on the 
education provided and clinical experience undertaken.  The discussion can then segue into 
finding ways to optimize the labor experience for their patients with the goal of a guiding a safe 
delivery and healthy baby.  At the end of the discussion, the participants will be asked to 
complete a project evaluation tool which will assess the efficacy of the project (Appendix B). 
5. Timetable/Flowchart 
First, I will administer a pre-education survey, in the form of a Likert scale to all 
participants.  The participants will have 1 week to complete the survey.  The survey will 
establish a baseline in order to determine if perceptions have changed in the future after the 
educational offering and subsequent clinical experience.  It will take participants ~ 15 minutes to 
complete the survey. 
Evidence-based education regarding the effects oxytocin and misoprostol have on labor 
outcomes gleaned from 12 scholarly articles will be provided by myself to the participants within 
the next 2 weeks.  I will offer a day presentation as well as an evening presentation to 
accommodate for varying shifts.  The presentation will last approximately 1.5 hours. 
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  The students and new graduate labor and delivery nurses will then have 3 months of 
clinical experience in labor and delivery.  This should provide suitable time for thorough clinical 
experience both administering oxytocin and misoprostol and observing the effects of each on 
delivery outcomes.  During this time, the participants should be keeping in mind the evidence 
provided while developing their perceptions of labor experiences after oxytocin and misoprostol 
administration. 
A post-education survey, also in the form of the same Likert scale as the pre-education 
survey would then be administered to all participants to see if perceptions have changed after 
receiving education and caring for women receiving oxytocin and misoprostol.  This survey will 
be administered within 1 week after the completion of clinical experience.  The survey would 
also be provided to students and nurses who did not receive the evidence-based education.  It 
will take ~15 minutes to complete the survey. 
Within 1 week, I will then guide a roundtable discussion among all participants in the 
project.  The guided discussion will last approximately 1 hour.  The goal of the guided discussion 
will be to provide an opportunity for the participants to discuss how they feel oxytocin and 
misoprostol affects labor experiences.  The participants will also be provided an opportunity to 
discuss how the educational offering and evidence provided affected their perceptions of labor 
experiences.  Finally, the participants would be guided to discuss how they can find and develop 
inventive, realistic ways to optimize labor and delivery based on the evidence provided and their 
perceptions of labor experiences.  An evaluation survey, which will take less than 10 minutes to 
complete, would then be provided to the participants at the end of the discussion to assess the 
efficacy of the educational offering, roundtable discussion, and the project overall.  
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Step 1: Pre-education Likert Scale survey  
Timeline: within 1 week. It will take ~15 minutes to complete the survey. 
Step 2: Evidence-based educational offering 
Timeline: 2 offerings to accommodate day and night shift.  Completion of 
both within next 2 weeks. Educational offering will last ~ 1.5 hours. 
Step 3: Clinical experience 
Timeline: Next 3 months 
Step 5. Guided roundtable discussion. 
Timeline: Within 1 week. Discussion to last ~1 hour. 
Step 4: Post education and clinical experience Likert scale survey. 
*Note: Also administer survey to non-participants 
Timeline: Within 1 week. It will take ~15 minutes to complete the survey 
Step 6: Administer project evaluation tool to participants 
Timeline: Upon conclusion of discussion. It will take ~10 minutes to complete 
the tool. 
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6. Planned Evaluation and Data Collection Methods 
An effective evaluation plan of this project includes administering 2 surveys, allowing 
time for practical clinical experience, guiding a roundtable discussion and gathering subsequent 
data in order to assess the efficacy of the project.  An initial pre-education survey in the form of a 
Likert scale needs to be administered at the beginning of the project.  In terms of the Likert scale, 
multiple statements will be provided with selections of “1” being strongly disagree, “2” disagree, 
“3” neutral, “4” agree, and “5” strongly agree.  The survey can be administered using Google 
Forms.  Data, including means with standard deviations, will then be extrapolated from the 
survey to include how the participants feel oxytocin and misoprostol affect labor experiences, 
both positively and negatively. 
After the initial survey, I will provide evidence-based education gathered from 12 
scholarly articles to the same participants on the effects oxytocin and misoprostol have on labor 
outcomes.  Then I will allow for 3 months clinical experience where the participants will care for 
women receiving oxytocin and misoprostol.  During this time, the participants will hopefully use 
the evidence provided to guide their perceptions while caring for women receiving these agents.  
After the clinical experience, I will administer a post-survey to the participants in the 
form of a Likert scale to assess their perceptions of labor experiences after the educational 
offering and clinical experience.  This survey will again be completed using Google Forms.  
Data, including means with standard deviations, will again be extrapolated from the survey to 
include how the participants currently feel oxytocin and misoprostol affect labor experiences, 
both positively and negatively.  Administering the survey after the educational offering and 
clinical experience will provide an opportunity for a meaningful comparison of the results 
against the pre-education survey.  Additionally, I will administer the same post-survey to 
students and new graduate labor and delivery nurses who did not receive the educational offering 
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in order to compare their results to the results of those who participated in the project and assess 
the effect of the educational offering.  
To compare the means in the pre and post surveys a student’s t-test will be conducted 
(Kim, 2015).  The t-test can also be used to compare results from the participants’ post survey to 
post survey results of those who did not receive the evidence-based education to determine if the 
education had a noticeable effect.  ANOVA can be used to assess the differences among the 
means (Sawyer, n. d.).  In this project, ANOVA will be used to assess the differences among the 
means within both the pre and post surveys of the participants.  It can also look for similarities 
and differences as well as determine if the evidence provided affected their outlooks on how 
these agents affect labor experiences.  These results will also illustrate whether the participants’ 
perceptions of labor experiences have changed after receiving the educational offering and 
completing clinical experience related to oxytocin and misoprostol administration.   
I will then guide a roundtable discussion with detailed talking points including how the 
participants feel oxytocin and misoprostol administration affects labor experiences as well as 
whether the evidence provided had any effect on their perceptions.  The participants will also be 
prompted to discuss innovative, realistic ways to optimize labor and delivery for their patients 
based on the evidence and clinical experience.  Finally, I will provide a post-discussion 
evaluation survey to the participants to include assessing the value of the roundtable discussion 
as well as the project itself.  
Data indicating a successful project would show that the evidence provided did, in fact, 
guide the participants’ opinions regarding the effects oxytocin and misoprostol have on delivery 
outcomes.  The results would indicate evolvement of labor perceptions after providing the 
evidence in an educational offering which would be indicated via comparing the pre and post 
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surveys as well comparing the results against the students and nurses who did not receive the 
evidence-based education.  Additionally, the participants engaging in meaningful discussions at 
the roundtable regarding optimizing labor experiences based on their perceptions and the 
evidence would also indicate completion of a successful project.   
7. Cost/Benefit Discussion 
The cost of implementing the project in the future will be minimal.  The only projected 
cost will be to provide a light snack during the educational offering, which can be provided for  
< $200.  Additional supplies necessary would include a internet access, a projector, and a 
meeting/conference room.  I anticipate being able to borrow these items in the future free of 
charge.   
The benefits to the project are vast.  New graduate labor and delivery nurses as well as 
student nurses will be provided evidence-based education on 2 of the most common agents they 
will administer in labor and delivery, oxytocin and misoprostol.  The education will be provided 
to them before any biases can be formed in order to allow them to form evidence-based 
perceptions of labor experiences of women receiving these agents.  This project will hopefully 
inspire them to take an invested role in improving labor and delivery experiences throughout 
their career and decreasing the C-section potential.  Furthermore, it can inspire the participants to 
encourage their patients to take a greater stake in their own healthcare decisions and possibly 
minimize the induction rates. 
Additionally, there are several possible financial benefits to the project.  An 
uncomplicated vaginal birth costs between $10,000 - $15,000 and an uncomplicated C-section 
costs between $20,000 - $25,000 (Montañez, 2019).  C-sections come with a myriad of risks and 
complications that are not as prevalent with a vaginal birth, including a longer hospital stay.  
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Therefore, if my participants fully engage and develop innovative ways to optimize labor and 
delivery, which includes decreasing the C-section rate, then potentially hundreds of thousands of 
dollars can be spared.   
8. Overall Discussion/Results 
The evidence is contradictory regarding the effects that oxytocin has on labor outcomes.  
However, most of the literature results agree that misoprostol confers significant benefit on 
achieving vaginal deliveries.  That being said, nurses can only react to the agent ordered by the 
physician.  However, nurses and students can still use their knowledge and skills related to the 
ordered agent to have a significant impact on laboring experiences.  Nurses and students need to 
come together to review the evidence to form educated opinions and perceptions of labor 
experiences and devise pioneering ways to boost laboring experiences unique to each induction 
agent administered. 
Being a benchmark and not an implementation project, there are no results from the 
Likert scale surveys to discuss.  In the future when I can implement, I would hope to see that the 
survey results reflect an enhanced perception among the participants of the effects oxytocin and 
misoprostol have on labor experiences.  I would also hope to see that the participants have used 
the evidence provided to engage in meaningful conversations amongst each other about ways to 
improve laboring experiences for expectant mothers. 
9. Recommendations 
Providing education on relevant evidence has shown to improve patient care and 
outcomes (Black, Balneaves, Garossino, Puyat, & Qian, 2014).  Therefore, after reviewing the 
evidence and statistics regarding C-section rates, I recommend implementing the project in BSN 
programs, specifically to obstetric students, and new graduate labor and delivery residency 
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programs.  I recommend presenting the project specifically to this population in order to educate 
the participants prior to any deep-set beliefs regarding oxytocin and misoprostol are formed. 
The next steps in order to successfully implement my project would be to gain the 
support of course leaders and Women’s Services Directors.  I have spoken to Theresa Rhodes, 
RN, who is the course leader of Maternal/Child at Lamar University and she is receptive to the 
project.  In the future, I will contact nurse manager at larger, metroplex hospitals in order to 
discuss the project.  Nurse leaders have indispensable attributes at their disposal to promote and 
enact change among the nurses they guide (Kodama & Fukahori, 2017).  Having their 
encouragement when not only ensure a successful implementation, but also that the project is 
sustainable in the long-term future. 
As a future MSN who hopes to be teaching obstetric students, I recommend 
implementing my project as part of the training of every successive obstetric class.  The project 
provides valuable evidence-based knowledge regarding oxytocin and misoprostol that the 
students can carry with them throughout their clinical experience.  However, it will be important 
to provide the educational offering at the start of the semester in order to allow time for adequate 
clinical experiences. 
For my facility, I recommend implementing the project at the start of the new graduate 
labor and delivery nurse residency program.  Providing the education prior to any experience on 
the labor and delivery floor will ensure that they have the most current evidence available before 
they form their own opinions based on experiences.  These new graduate nurses can then take 
what they have learned, and form educated opinions based on the evidence and subsequent 
clinical experience.  They can also use the education provided to prompt meaningful discussions 
amongst themselves and their preceptors about ways to improve delivery experiences. 
 ENHANCING PERCEPTIONS                                                                                             24 
Even though this project focuses on providing education to new graduate labor and 
delivery nurses and students, I feel it is important to also disseminate the evidence to my 
experienced colleagues and nursing leadership as well.  All too often experienced nurses get in 
the mindset of knowing what is best based on their experience.  While their clinical experiences 
and knowledge is certainly invaluable, it is important to remember that nursing and medicine 
change constantly and be open to viewing new evidence as it becomes available.  Therefore I 
recommend viewing the evidence I have provided with an open mind and being willing to 
engage in discussions with the project participants about the study results and ways to improve 
laboring patient outcomes and encourage their patients to have a voice regarding their medical 
decisions surrounding labor and delivery.  
Conclusion 
 The statistics are clear in showing that the C-section and induction rates have steadily 
risen in the past several decades.  The literature is divided regarding the effects that oxytocin has 
on delivery outcome while depicting misoprostol conferring significant benefits on achieving a 
vaginal delivery.  New graduate labor and delivery nurses as well as student nurses need to use 
the statistics as well as the evidence present in the literature to enhance their perceptions of labor 
experiences in order to engage in meaningful conversations both amongst each other and with 
their preceptors and discuss finding innovative, nursing interventions that can optimize the 
birthing experience.  Understanding the effects these agents have on delivery outcomes can, 
hopefully, encourage nurses and students to continually seek out current evidence that will guide 
them in increasing quality of care and provide a safe delivery for both mother and baby.  
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Appendix A: Pre and Post Education Survey 
1: Strongly Disagree 
2: Disagree 
3: Neutral 
4: Agree 
5: Strongly Agree 
1. I feel oxytocin use in labor increases the occurrence of a cesarean section. 
1 2 3 4 5 
2. I feel misoprostol use in labor increases the occurrence of a cesarean section. 
1 2 3 4 5 
3. I feel oxytocin use in labor increases the occurrence of a vaginal delivery. 
1 2 3 4 5 
4. I feel misoprostol use in labor increases the occurrence of a vaginal delivery. 
1 2 3 4 5 
5. I feel oxytocin use in labor positively affects labor experiences. 
1 2 3 4 5 
  
 ENHANCING PERCEPTIONS                                                                                             30 
Appendix A: Continued 
6. I feel misoprostol use in labor positively affects labor experiences. 
1 2 3 4 5 
7. I feel oxytocin use in labor negatively affects labor experiences. 
1 2 3 4 5 
8. I feel misoprostol use in labor negatively affects labor experiences. 
1 2 3 4 5 
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Appendix B: Project Evaluation Tool 
1: Strongly Disagree 
2: Disagree 
3: Neutral 
4: Agree 
5: Strongly Agree. 
1. The objectives of the project were clearly stated. 
1 2 3 4 5 
2. The educational offering was informative and met the objectives. 
1 2 3 4 5 
3. I learned new information from the evidence-based education about oxytocin that 
impacted my perceptions of labor experiences. 
1 2 3 4          5  
4. I learned new information from the evidence-based education about misoprostol that 
impacted my perceptions of labor experiences. 
1 2 3 4          5 
5. The prompts provided during the roundtable discussion were appropriate and met 
objectives. 
1 2 3 4 5 
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Appendix B: Continued 
6. The roundtable discussion promoted meaningful dialogue amongst colleagues 
regarding perceptions of labor experiences. 
1 2 3 4 5 
7. The roundtable discussion promoted meaningful dialogue amongst colleagues 
regarding ways to improve labor and delivery experiences. 
1 2 3 4 5 
8. I will continue to use the evidence provided to engage in profound dialogue with my  
colleagues to find innovative ways to improve best practice in labor and delivery. 
1 2 3 4 5 
9. The project was beneficial to me and by extension, my patients.  
1 2 3 4 5 
10. The entire project was meaningful and satisfactory. 
1 2 3 4 5 
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Appendix C: Evaluation Table 
 
PICOT Question: In nursing students and/or new graduate labor and delivery nurses (P), how does education regarding 
delivery outcomes of labor inducing agents, oxytocin and misoprostol specifically, (I) compare to no education (C) affect their 
perceptions of labor experiences (O) over 6 months following education of the intervention group (T)? 
PICOT Question Type (Circle): Intervention   Etiology    Diagnosis or Diagnostic Test    Prognosis/Prediction   Meaning 
 
Caveats  
1) The only studies you should put in these tables are the ones that you know answer your question after you have done rapid 
critical appraisal (i.e., the keeper studies) 
2) Include APA reference 
3) Use abbreviations & create a legend for readers & yourself 
4) Keep your descriptions brief – there should be NO complete sentences 
5) This evaluation is for the purpose of knowing your studies to synthesize. 
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Citation: 
(i.e., 
author(s), 
date of 
publication, 
& title) 
Conceptual 
Framework 
Design/ 
Method 
 
Sample/ 
Setting 
Major 
Variables 
Studied and 
Their 
Definitions 
 
Measurement of 
Major Variables 
Data 
Analysis 
 
Study Findings 
Strength of the Evidence (i.e., level of evidence 
+ quality [study strengths and weaknesses]) 
Author, 
Year, Title 
 
Theoretical 
basis for 
study 
 Qualitative  
Tradition 
 Number, 
Characteristi
cs,  
Attrition rate 
& why? 
Independent 
variables 
(e.g., IV1 =  
IV2 =) 
 
Dependent 
variables (e.g., 
DV = ) 
What  scales were 
used to measure 
the outcome 
variables (e.g., 
name of scale, 
author, reliability 
info [e.g., 
Cronbach 
alphas]) 
 
 
 
What stats 
were used 
to answer 
the 
clinical 
question 
(i.e., all 
stats do 
not need 
to be put 
into the 
table) 
Statistical findings or 
qualitative findings (i.e., 
for every statistical test 
you have in the data 
analysis column, you 
should have a finding) 
• Strengths and limitations  of the study 
• Risk or harm if study intervention or 
findings implemented 
• Feasibility of use in your practice  
• Remember: level of evidence (See Melnyk 
& Finout-Overholt, pp. 32-33) + quality of 
evidence = strength of evidence & confidence 
to act 
• Use  the USPSTF grading schema 
http://www.ahrq.gov/clinic/3rduspstf/ratings.h
tm  
Acharya et 
al., 2017, 
Outcome of 
misoprostol 
and oxytocin 
induction in 
labour 
None stated Hospital 
based 
observati
onal 
study 
N=205 (miso 
n=138, OT 
n=50) 
 
Pregnant 
women > 37 
weeks 
gestation with 
singleton 
pregnancies. 
Most were < 
24 years old 
and NW 
 
 
IV: IOL miso 
or OT 
 
DV: MOD, 
induction to 
delivery 
interval, 
mat/neonatal 
outcomes 
None stated Percentages Most women achieved 
SVD (n=138, 67.3%) 
 
C/S rates were comparable 
between OT (n=14, 28%) 
and miso (n=39, 28.3%) 
 
C/S rose when OT given 
after IOL with miso failed 
(n=15, 88%) 
 
OT quicker IOL to delivery 
time in <12h (n=20, 
43.5%) compared to miso 
(n=25, 18.4%) 
Strengths: included MW and NW, accounted for 
OT after IOL miso failure, accounted for IOL 
indication, described reason for C/S 
Limitations: not randomized, small sample size, 
does not account for comorbidities 
Risk: changing protocol regarding OT after IOL 
miso failure when it might be necessary 
Feasibility: low-moderately feasible to 
implement changes. Highly feasible to encourage 
further studies 
USPSTF: moderate level of certainty, grade C 
Level of evidence: 6 
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Sharada et 
al., 2018, 
Misoprostol 
and oxytocin 
in induction 
of labor 
None Stated Hospital 
based 
observati
onal 
study 
N=327 (miso 
n=183, OT 
n=144) 
 
Pregnant 
women > 37 
weeks 
gestation with 
singleton 
pregnancies. 
Most between 
20-25 years 
old 
 
AR not 
identified 
 
P.K. Das 
Institute of 
Medical 
Sciences, 
Kerala 
IV: IOL miso 
or OT  
 
DV: MOD, 
time for 
induction, 
induction to 
delivery, Apgar 
scores, mat and 
neonatal 
complications 
None stated Percentages 
 
 
 
 
 
 
Mean, 
standard 
deviation 
Most women achieved 
SVD (64.8%) 
 
C/S slightly higher with 
OT (n=52, 36%) compared 
to miso (n=60, 32.7%) 
 
OT quicker IOL to delivery 
interval (mean 18.4 h 
standard deviation 3.2h) 
compared to miso (19.1h 
standard deviation 2.8h) 
 
OT quicker time for onset 
of labor (mean 7.2h 
standard deviation 0.7h) 
compared to miso (mean 
12.7h standard deviation 
1.2h) 
 
Strengths: included MW and NW, described 
administration and titration doses for miso and 
OT, accounts for side effects 
Limitations: does not account for reason for IOL, 
not randomized, does not account for mitigating 
factors, small sample size 
Risk: changing protocol regarding OT based on 
an observational study, giving OT immediately 
to women who are not sufficiently dilated due to 
desire for quicker labor 
Feasibility: low-moderately feasible to 
implement changes. Highly feasible to encourage 
further studies 
USPSTF: moderate level of certainty, grade C 
Level of evidence: 6 
Wallstrom et 
al., 2017, 
Labor 
induction 
with orally 
administered 
misoprostol: 
A 
retrospective 
cohort study 
None stated Retrospe
ctive 
cohort 
study 
N=4002 (miso 
n=1675, OT 
n=228) 
 
Pregnant 
women > 34 
weeks 
gestation with 
viable 
singleton fetus 
 
AR not 
identified 
 
Sokersjukhuse
t, Stockholm, 
Sweden 
IV: method of 
induction 
 
DV: C/S, cord 
blood pH at 
delivery, 
Apgar score 
<7 after 5 
minutes, 
active time of 
labor, 
postpartum 
hemorrhage 
None stated OR, CI 
  
 
 
Percentages 
IOL with immature cervix 
increased C/S (OR 1.7, 
95% CI, 1.5-2.1) 
 
IOL miso showed lowest 
C/S at start of induction 
with immature cervix 
(n=308, 18%) 
 
IOL oral miso showed 
lowest risk of C/S overall 
with immature cervix for 
MW (11%, p<0.01) and 
NW (23%, p<0.01) 
 
Without considering other 
factors, OT showed lowest 
risk of C/S (n=28, 12%) 
 
Majority of miso patients 
had SVD (n=1367, 82%) 
Strengths: The study accounted for additional 
C/S risk factors, large sample size, all data was 
check post delivery which will increase 
reliability 
Limitations: Women included were older and 
more educated than the national average. There 
was no randomization and the study was done in 
retrospect. 
Risk: choosing a specific agent without regard 
for a patient's specific situation based on risk of 
C/S presented in the study 
Feasibility: moderately feasible to guide 
induction agent selection and implementation 
based on risk factors 
USPSTF: High level of certainty, Grade  
Level of evidence: 4 
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Mishanina et 
al., 2014, 
Use of labour 
induction and 
risk a 
cesarean 
delivery: A 
systematic 
review and 
meta-analysis 
None stated Systemat
ic review 
and 
meta-
analysis 
N=31,085 
 
Pregnant 
women with 
viable 
singleton fetus 
 
AR not 
identified 
 
157 RCTs 
included  
IV: method of 
induction, 
placebo, 
expectant 
management 
 
DV: C/S 
No instruments 
noted 
RR, CI, 
heterogene
ity 
 
IOL with OT no increased 
risk for C/S RR 1.03 (95% 
CI 0.83-1.28), I² 0.0% 
 
IOL with AROM increased 
risk for C/S RR 0.96 
(95%CI 0.72-1.29), I² 
0.0% 
 
IOL with miso decreased 
risk for C/S RR 0.62 (95% 
CI 0.48-0.81), I² 0.0 
Strengths: No language or geographic restrictions 
on RCTs included, accounts for numerous IOL 
methods, it is a systematic review 
Limitations: Blinding was not clearly reported in 
half the studies, did not account for all 
contributing factors to a C/S, did not account for 
all reasons for induction, errors in coding may 
have occurred 
Risk: Contradicting results may lead to no 
change regarding OT 
Feasibility: moderately feasible to continue to 
use OT, but limit use of AROM in combination 
USPSTF: high level of certainty, grade B 
Level of evidence: 1 
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Mikolajczyk 
et al., 2016, 
Early versus 
late 
admission to 
labor affects 
labor 
progression 
and risk of 
cesarean 
section in 
nulliparous 
women 
None stated Descripti
ve 
observati
onal 
study 
N=1202 
 
Nulliparous 
women with 
singleton, 
vertex 
pregnancies 
and 
spontaneous 
labor onset 
 
AR not 
identified 
 
Military 
hospital in 
Hawaii 
IV: dilation on 
admission, OT 
administration 
 
DV: C/S, SVD, 
instrumental 
SVD 
No instruments 
noted 
Percentages
, Chi 
squared 
Total sample: AUG OT 
increased C/S (12.5 % 1st 
stage of labor, 6.6 % 2nd 
stage of labor, p<0.0001) 
 
No association between 
AUG OT and C/S in 
women 0.5-1.5 cm dilated 
on admission and 4.5-5.5 
cm on admission (11.8% 
1st stage, 5.2% second 
stage, p=0.86) and (7.6% 
1st stage, 0% second stage, 
p=.011) respectively 
 
Association between AUG 
OT and C/S in women 
dilated 2.5-3.5 cm on 
admission (12.6% 1st 
stage, 8.6% second stage, 
p=0.0007) 
Strengths: accounts for dilation on admission, in-
depth analysis of risk of cesarean during labor, 
homogenous database of nulliparous women 
Limitations: only accounts for nulliparous 
women, does not account for reason for AUG, it 
is an observational study, cervical dilation is 
subjective  
Risk: changing protocol regarding OT based on 
an observational study, giving OT immediately 
to women who are not sufficiently dilated 
Feasibility: low-moderately feasible to 
implement OT changes. Highly feasible to 
encourage further studies 
USPSTF: moderate level of certainty, grade C 
Level of evidence: 6 
Hurakadli, 
2016, 
Partographic 
comparison 
of 
spontaneous 
labour with 
oxytocin and 
prostaglandin 
induced 
labour 
None stated Partogra
phic 
comparis
on 
(randomi
zed 
controlle
d trial) 
N=100 
 
Nulliparous 
women, 
singleton, 
vertex 
presentation 
 
AR not 
identified 
 
Location not 
identified 
IV: OT, oral 
miso, vaginal 
miso, SL 
 
DV: IOL-
delivery 
interval, MOD, 
mat and fetal 
complications 
No instruments 
noted 
ANOVA, 
mean, 
standard 
deviation 
 
Percentages
, Chi 
squared 
IOL OT decreased IOL-
delivery time (735+238, 
F=5.56, p<0.05) compared 
to vaginal miso 
(1080+510, F=5.56, 
p<0.05) and oral miso (803 
+277, F=5.56, p<0.05) 
 
 
IOL OT had highest risk of 
C/S (20%, x²=12.92, 
p=0.17) 
 
IOL oral miso had lowest 
risk of C/S (4%, x²=12.92, 
p=0.17) 
 
IOL vaginal miso had 
lower C/S risk than OT 
(8%, x²=12.92, p=0.17) 
 
 
Strengths: participants were randomly allocated 
to groups, accounts for indication of induction, 
accounts for more than one induction method 
Limitations: blinding was not done, only 
accounts for nulliparous women, reason for C/S 
was not accounted for, small sample size 
Risk: increasing use of OT to decrease length of 
labor 
Feasibility: moderately feasible to regulate use of 
OT for IOL on nulliparous women 
USPSTF: moderate level of certainty, grade B 
Level of evidence: 2 
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Alfirevic et 
al., 2016, 
Methods to 
induce 
labour: A 
systematic 
review, 
network 
meta-analysis 
and cost-
effectiveness 
analysis 
None stated Systemat
ic review 
and 
network 
meta-
analysis  
N>100,000 
 
Pregnant 
women in 3rd 
trimester  
 
AR not 
identified 
 
Liverpool 
Women's 
Hospital; 611 
studies 
included in 
systematic 
review from 
facilities 
throughout the 
world 
 
  
 
IV: method of 
induction 
 
DV: VD24, 
C/S, UH with 
FHR changes, 
serious neonatal 
morbidity or 
death, serious 
mat morbidity 
or death, ID, 
mat 
satisfaction, 
NICU 
admission, 
Apgar <7 at 5 
minutes, cost 
effectiveness 
No instruments 
noted 
OR, CI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Heterogene
ity, mean,  
Standard  
deviation 
IOL OT with AROM 
lowest risk for no VD24, 
OR = 0.05 (95% CI 0.07-
0.32) 
 
IOL OT moderately high 
risk for no VD24, OR = 
0.20 (95% CI 0.21-1.97) 
 
IOL OT with AROM was 
medium risk for C/S OR = 
0.89 (95% CI 0.57-1.34) 
 
IOL OT medium risk for 
C/S OR = 0.93 (95%CI 
0.75-1.14) 
 
IOL titrated oral miso 
lowest risk for C/S OR = 
0.62 (95% CI, 0.47-0.80) 
 
IOL vaginal miso low dose 
(0.70, 95% CI 0.57-0.85), 
oral miso high dose (0.72, 
95% CI 0.58-0.88), and 
vaginal miso high dose 
(0.73, 95% CI 0.59-0.88) 
all had lower risk for C/S 
than OT  
 
 
No results provided 
Strengths: No language restrictions on RCTs 
included, accounted for a multitude of IOL 
methods, it was a systematic review, a variety of 
outcomes were studied 
Limitations: Meta-analysis was only done on 6 
out of 9 outcomes, not all trials provided 
important data, VD24 was underreported, 
maternal mortality, severe maternal morbidity, 
infant mortality rate were underreported, cost-
effective analysis was limited to short-term 
outcomes, few trials considered patient 
preference 
Risk: Basing IOL methods on cost instead of 
medical indications, increasing use of OT with 
AROM to achieve VD24 when other methods 
may be preferable to the situation 
Feasibility: highly feasible to use OT with 
AROM to increase VD 24; moderately feasible to 
decrease C/S with OT IOL 
USPSTF: high level of certainty, grade B 
Level of evidence: 1 
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Aalami-
Harandi et 
al., 2013, 
Induction of 
labor with 
titrated oral 
misoprostol 
solution 
versus 
oxytocin in 
term 
pregnancy: 
randomized 
controlled 
trial 
None stated Randomi
zed 
controlle
d trial 
N=256 
Miso: n=128 
OT: n=128 
 
Nulliparity, 
Bishop score 
about 3, mean 
age about 25 
 
AR not 
identified 
 
Gynecology 
Department of 
Tajrish 
Hospital in 
Tehran, Iran 
 
 
IV: miso or OT 
administration 
 
DV: primary 
outcomes: 
MOD, time 
from IOL to 
delivery, time 
from IOL to 
active labor, 
successful IOL 
within 12, 18, 
and 24 hours, 
serious mat 
comp (UH, UR, 
PA) 
Secondary 
outcomes: PPH, 
abnormal 
changes in mat 
VS, GI s/s, 
neonatal status, 
Apgar scores, 
fetal distress, 
fetal death, 
admission to 
the NICU 
No instruments 
noted 
Mean, 
standard 
deviation 
 
 
 
 
 
 
 
 
Percentages 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mann-
Whitney U, 
Chi-
squared, T-
test 
Time from IOL to active 
labor was shorter in OT 
group (n=114, 10.1+6.1, 
p=0.002) compared to 
miso (n=126, 12.9+5.4, 
p=0.002)  
IOL to SVD was shorter in 
OT group (n=79, 13.2+7.7, 
p=0.01) compared to miso 
(n=122, 15.6+5.1, p=0.01)  
 
Miso group had higher rate 
of SVD at 24 hours 
(n=122, 79.9%, p<0.001) 
compared to OT (n=79, 
61.7%, p<0.001) 
Miso SVD higher at 18 
hours (n=86, 67.1%, 
p=0.02) compared to OT 
(n=68, 53.1%, p=0.02) 
OT C/S higher (n=49, 
38.3%, p<0.001) compared 
to miso (n=26, 20.3%, 
p<0.001) 
 
 
No results given 
 
 
Strengths: included 2 of the most common IOL 
methods. Accounted for several clinical 
characteristics. Accounted for several maternal 
and neonatal outcomes. Treatment groups were 
assigned randomly. 
Limitations: Blinding was not done. AROM vs 
SROM were not considered. Reasons for C/S 
were not thoroughly explained. Dose variations 
were not considered. 
Risk: Increase in miso for most labor inductions 
despite the patient needing a quicker delivery that 
OT could affect. 
Feasibility: moderately feasible to decrease OT 
administration for IOL 
USPSTF: moderate level of certainty, Grade B 
Level of evidence: 2 
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Saccone et 
al., 2017, 
Discontinuin
g oxytocin 
infusion in 
the active 
phase of 
labor 
None stated Systemat
ic 
Review 
and meta 
analysis 
N=1538 
d/c OT: n=764 
continue OT: 
n=774 
 
Pregnant 
women 36 
weeks or 
greater with a 
singleton in 
cephalic 
presentation 
undergoing 
IOL. 
AR not 
identified 
 
1 trial from 
the United 
States 
One trial from 
Europe  
Both high and 
low income 
countries 
included 
IV: OT IOL for 
entire labor, 
discontinue OT 
during IOL 
once active 
labor achieved 
 
DV: cesarean 
section 
No instruments 
noted 
I² 
 
 
 
 
 
Mean, CI,  
 
 
 
 
 
Percentages
,RR 
 
 
 
 
 
 
 
Heterogeneity ranged from 
low (0%) to high (96%) 
between trials; no 
inconsistency in risk 
estimates (0%) for CS 
 
d/c OT longer length of 
active labor (mean 
difference 27.65 
minutes)(95% CI 3.94-
51.36) compared to OT 
continuation 
d/c OT had lower risk of 
C/S (9.3% compared to 
14.7% RR 0.64, 95%CI 
0.48-0.87) 
d/c OT had lower risk of 
uterine tachysystole (6.2% 
compared to 13.1%, RR 
0.53, 95% CI 0.33-0.84)  
Strengths: Included trials worldwide, a formal 
meta-analysis was included in the systematic 
review, all the trials were RCTs. 
Limitations: None of the trials was large. Only 
one was from the United States. There was no 
subgroup analysis by parity. No trials were 
identified on d/c of OT after augmentation. Trials 
were different regarding OT dosing and delivery 
protocol. Only three RCTs used a placebo in the 
control group. Data regarding parity, cervical 
ripening and admission Bishop score were 
limited. Around half or greater of the included 
women were nulliparous and a separate analysis 
on parity was not done. 
Risk: d/c OT prematurely leading to longer labors 
and increased complications. 
Feasibility: highly feasible to d/c OT after active 
labor has been achieved. 
USPSTF: high certainty that the net benefit is 
moderate, grade B 
Level of evidence: 1 
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Tam et al., 
2012, 
Delivery 
outcomes in 
women 
undergoing 
elective labor 
induction. 
 
 
 
 
 
 
 
 
 
 
 
None stated Retrospe
ctive 
cohort 
study 
N=848 
SVD: n=694 
C/S: n=154 
AR:1159 
women 
identified, 848 
included in 
study. 
Characteristics
: LR, 
pregnant, 
between or at 
39 and 41 
weeks 
gestation, IOL 
Setting: 
Resurrection 
Health 
Care/St. 
Joseph 
Hospital, 
Chicago 
IV: Induction 
method (Foley 
bulb, AROM, 
cervidil, miso, 
OT) 
 
DV: delivery 
method (SVD 
or C/S) 
No instruments 
noted 
 
 
 
 
 
 
 
 
ANOVA 
 
 
 
 
Tukey HSD 
 
 
Descriptive 
Statistics 
 
 
 
 
OR 
 
 
 
 
Chi 
Squared 
 
Significant difference 
between length of 
induction based on 
methods 
 
 OT only method showing 
decreased time 
 
OT alone results in SVD 
(n=525, 75.7%) OT on 
NW with unfavorable CE 
resulted in more C/S (α = 
0.05); miso had lowest C/S 
rate (1.95%) 
 
 Odds for SVD are 11x 
higher with OT than Foley 
bulb 
 
 
IOL (p = 0.0161), 
gestational age (p = 
0.0550) and length of 
induction (p < 0.0001) are 
significantly related to the 
delivery method. All used 
α = 0.05 for significance. 
 
 
Strengths: Large sample size with diverse 
population, accounts for several induction 
methods 
Limitations: does not account for length of labor 
before C/S, reason for C/S, fetal tolerance not 
assessed 
Risk: Increase in elective inductions despite no 
medical necessity.  
Feasibility: highly feasible to enhance induction 
guidelines 
USPSTF: High level of certainty, Grade B 
Level of evidence: 4 
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Davey & 
King, 2016, 
Caesarean 
section 
following 
induction of 
labour in 
uncomplicate
d first births- 
a population-
based cross-
sectional 
analysis of 
42,950 births 
None stated Descripti
ve Study 
N=42,950 
 
Most women 
between 25-34  
Most between 
39-40 weeks 
gestation with 
no AUG and 
had SVD 
 
AR not 
identified 
 
Victoria, 
Australia 
 
IV: IOL and 
method of 
induction 
DV: delivery 
method 
No instruments 
noted 
OR 
 
 
 
Relative 
Risk Ratio 
and 
Multinomal 
logistic 
regression 
 
 
IOL more likely to have 
CS. 2.54 (95% CI, 2.4-2.7) 
p<0.0001 
 
AUG OT 6.17 (95% CI, 
5.7-6.7) adjusted 2.89 
(95% CI, 2.6-3.2) 
p<0.0001 
AUG AROM & OT 6.51 
(95% CI, 5.9-7.2) adjusted 
2.55 (95% CI, 2.3-2.8) 
p<0.0001 
IOL OT 7.37 (95% CI, 4.4-
12.2) adjusted 4.13 (95% 
CI, 2.4-7.0) p<0.0001 
IOL PG & OT 11.83 (95% 
CI, 8.4-16.6) adjusted 4.06 
(2.8-5.8) p<0.0001 
IOL AROM & OT 3.86 
(95% CI, 3.3-4.6) adjusted 
1.82 (95% CI, 1.5-2.2) 
p<0.0001 
IOL PG& AROM&OT 
10.19 (95%CI, 8.8-11.9) 
adjusted 3.79 (95%CI, 3.2-
4.5) p<0.0001 
 
 
 
Strengths: Large sample size, accounts for several 
induction methods alone and in combination. 
Accounts for AUG. High level of accuracy. 
Limitations: does not account for indication of  
AUG, reason for C/S, and length of labor trial 
prior to C/S 
Risk: Increase in post-dates labors or inductions. 
Larger infants leading to more operative vaginal 
deliveries 
Feasibility: highly feasible to decrease elective 
inductions 
USPSTF: High level of certainty, Grade A 
Level of evidence: 6 
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Hidalgo-
Lopezosa et 
al., 2016, 
Labor  
stimulation 
with 
oxytocin: 
Effects on 
obstetrical 
and neonatal 
outcomes 
None stated  Descripti
ve Study 
N=338 
 
Pregnant 
women with 
spontaneous 
labor assisted 
 
AR not 
identified 
 
Tertiary 
hospital in 
south of Spain 
 
IV: OT 
stimulation 
during labor 
DV: Type of 
delivery (C/S, 
SVD, ID) 
Advanced 
neonatal 
resuscitation 
5-minute Apgar 
scores 
Arterial pH 
values of 
umbilical cord 
blood 
3rd and 4th 
degree vaginal-
perineal 
lacerations 
 
 
No instruments 
noted 
OR, Chi 
squared 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
t-test 
 
 
 
 
 
AUG OT NW C/S n=45, 
crude OR = 5.76 (95% CI 
2.55-13.0), p<0.0001, 
No OT NW C/S n=8, crude 
OR = 5.76 (95% CI, 2.55-
13.0), p<0.0001  
AUG OT MW C/S n=8, 
crude OR= 6.95 (95% CI 
1.41-34.27), p=0.014, 
No OT NW C/S n=2, crude 
OR = 6.95 (95% CI, 1.41-
34.27), p=0.014, 
AUG OT NW DOL n=5.1, 
crude OR = 1.62 (95% CI, 
0.95-2.29), p<0.0001 
No OT NW DOL n=6.8, 
crude OR = 1.62 (95% CI, 
0.95-2.29), p<0.0001 
 
 
 
No results provided 
 
 
 
Strengths: Accounts for several outcomes of 
oxytocin for both mother and fetus, accounts for 
both primiparous and multiparous women 
Limitations: small sample size, only studies 
mothers at one hospital, does not account for 
reason for C/S and length of labor prior, does not 
account for induction  
Risk: No change in oxytocin use for inductions 
Feasibility: moderately feasible to decrease 
oxytocin use 
USPSTF: Moderate level of certainty, Grade B 
Level of evidence: 6 
Legend: AR = attrition rate, AUG = augmentation of labor, AROM = artificial rupture of membranes, CE = cervical exam, comp = 
complications, C/S = cesarean section, d/c = discontinue, DP = dinoprostone, DOL = duration of labor, EBL = estimated blood loss, 
EM = expectant management, FHR = fetal heart rate, GI = gastrointestinal, IOL = induction of labor, LR = low-risk, mat = maternal, 
MOD = mode of delivery, miso = misoprostrol MW = multiparous women, NICU = neonatal intensive care unit, NW = nulliparous 
women, OD = operative delivery, OT = oxytocin, PA = placental abruption, PG = prostaglandin, PPH = postpartum hemorrhage, SL = 
spontaneous labor, SROM = spontaneous rupture of membranes, s/s = signs and symptoms, SVD = spontaneous vaginal delivery, UH 
= uterine hyperstimulation, UR = uterine rupture, VD24 = vaginal delivery within 24 hours, VS = vital signs 
 
 
 
***Prompts for each column – please do not repeat the headings, just provide the data                                                                                   
Used with permission, © 2007 Fineout-Overholt 
